Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Implantable Cardioverter Defibrillators (ICDs) Market Expected To Expand Between 2025 And 2029?
The implantable cardioverter defibrillators (ICDs) market has experienced significant expansion in recent years. Its value is projected to rise from $3.76 billion in 2024 to $3.98 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.8%. The historical growth of this market can be linked to factors such as a higher prevalence of sudden cardiac arrest, the integration of implantable cardioverter defibrillators into secondary prevention strategies for sudden cardiac arrest, increasing public understanding, an expanding elderly demographic, favorable policies from governments and healthcare bodies, and better access to healthcare.
The implantable cardioverter defibrillators (icds) market is anticipated to experience robust expansion over the coming years. This sector is projected to reach $4.95 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.6%. The expansion during this forecast period stems from factors such as the increasing acceptance of implantable defibrillators, a heightened demand for tailored cardiac care, the growing incidence of cardiac rhythm disorders, and increasing requirements in developing economies. Prominent trends for the same period include ongoing technological innovations, the introduction of subcutaneous ICDs designed to eliminate transvenous leads, the rising preference for combination ICD devices offering pacemaker capabilities, refined sensing and detection algorithms, steady progress in wireless charging and battery technologies, and the incorporation of artificial intelligence (AI) within healthcare and data analytics.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20839&type=smp
What Are The Drivers Pushing New Developments In The Implantable Cardioverter Defibrillators (ICDs) Market?
The growing occurrence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the implantable cardioverter defibrillators (ICDs) market in the future. These conditions, known as cardiovascular diseases (CVDs), encompass various heart and blood vessel disorders like heart attacks, strokes, and high blood pressure, frequently resulting from elements such as unhealthy eating, insufficient physical activity, smoking, and genetic predispositions. The rising incidence of cardiovascular diseases is largely fueled by an aging global populace, detrimental lifestyle habits, and an uptick in risk elements including obesity, diabetes, and hypertension. Implantable cardioverter defibrillators (ICDs) play a crucial role in managing cardiovascular diseases (CVDs) through the delivery of vital electrical impulses designed to normalize heart rhythms for individuals susceptible to sudden cardiac arrest. A notable example is data from the Australian Institute of Health and Welfare, an Australian government body, which reported in December 2023 that doctor-confirmed fatalities attributed to coronary heart disease (CHD) climbed to 14,100 in 2021 and subsequently to 14,900 in 2022. Consequently, the growing occurrence of cardiovascular diseases (CVDs) is a primary catalyst for the expansion of the implantable cardioverter defibrillators (ICDs) market.
What Are The Major Segment Categories Driving The Implantable Cardioverter Defibrillators (ICDs) Market Growth?
The implantable cardioverter defibrillators (icds)market covered in this report is segmented –
1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs); Dual Chamber Implantable Cardioverter Defibrillators (ICDs); Biventricular Devices
2) By Applications: Bradycardia; Tachycardia; Heart Failure; Other Applications
3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs; MRI-Compatible Single Chamber ICDs; Wireless Single Chamber ICDs
2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs; MRI-Compatible Dual Chamber ICDs; Wireless Dual Chamber ICDs
3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator); CRT-P (Cardiac Resynchronization Therapy Pacemaker); Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)
Which Key Trends Are Expected To Influence The Implantable Cardioverter Defibrillators (ICDs) Market In The Coming Years?
Leading companies operating in the implantable cardioverter defibrillators (ICDs) market are prioritizing technological innovations, such as low current consumption defibrillators, to boost device efficiency, extend battery duration, and improve patient comfort. These low current consumption defibrillators are engineered to deliver electrical shocks to the heart utilizing less energy, which aids in prolonging battery life while guaranteeing effective treatment of arrhythmias. For instance, in October 2023, MicroPort CRM, a France-based medical devices company, launched the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan, marking a significant advancement in cardiac care technology. These devices incorporate innovative capabilities, including low current consumption for extended battery life and MRI compatibility, ensuring their suitability for patients requiring imaging procedures. The ULYS ICD specifically integrates the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, enhancing patient safety during MRI scans. Additionally, the INVICTA lead achieved a 100% implantation success rate and a 97.4% complication-free rate in clinical trials, underscoring its reliability and effectiveness.
Who Are The Top Performing Companies In The Implantable Cardioverter Defibrillators (ICDs) Market In Recent Years?
Major companies operating in the implantable cardioverter defibrillators (ICDs) market are Abbott Laboratories, Medtronic Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., LivaNova PLC, MicroPort Scientific Corporation, Japan Lifeline Co. Ltd., AtriCure Inc., Physio-Control Inc., BPL Medical Technologies Private Limited, Kestra Medical Technologies Inc., CU Medical Germany GmbH, Metrax GmbH, Intermedics Inc., Sorin Group S.p.A.
Download The Full Report For Exclusive Market Findings:
How Does The Implantable Cardioverter Defibrillators (ICDs) Market Perform Across Key Geographic Regions?
North America was the largest region in the implantable cardioverter defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardioverter defibrillators (ICDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Implantable Cardioverter Defibrillators (ICDs) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=20839&type=smp
Browse Through More Reports Similar to the Global Implantable Cardioverter Defibrillators (ICDs) Market 2025, By The Business Research Company
Implantable Defibrillators Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/implantable-defibrillators-global-market-report
Automated External Defibrillators Aed Global Market Report 2025
Implantable Infusion Pumps Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model